|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xi S and Grandis JR: Gene therapy for the
treatment of oral squamous cell carcinoma. J Dent Res. 82:11–16.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Magrath I and Litvak J: Cancer in
developing countries: Opportunity and challenge. J Natl Cancer
Inst. 85:862–874. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kramer RH, Shen X and Zhou H: Tumor cell
invasion and survival in head and neck cancer. Cancer Metastasis
Rev. 24:35–45. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ziober AF, Falls EM and Ziober BL: The
extracellular matrix in oral squamous cell carcinoma: Friend or
foe? Head Neck. 28:740–749. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berenson JR, Yang J and Mickel RA:
Frequent amplification of the bcl-1 locus in head and neck squamous
cell carcinomas. Oncogene. 4:1111–1116. 1989.PubMed/NCBI
|
|
7
|
De Herdt MJ and de Jong RJ Baatenburg: HGF
and c-MET as potential orchestrators of invasive growth in head and
neck squamous cell carcinoma. Front Biosci. 13:2516–2526. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kalyankrishna S and Grandis JR: Epidermal
growth factor receptor biology in head and neck cancer. J Clin
Oncol. 24:2666–2672. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rørth P: Collective cell migration. Annu
Rev Cell Dev Biol. 25:407–429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Neiva KG, Zhang Z, Miyazawa M, Warner KA,
Karl E and Nör JE: Cross talk initiated by endothelial cells
enhances migration and inhibits anoikis of squamous cell carcinoma
cells through STAT3/Akt/ERK signaling. Neoplasia. 11:583–593. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Friedl P and Wolf K: Plasticity of cell
migration: A multiscale tuning model. J Cell Biol. 188:11–19. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lemmon MA and Schlessinger J: Cell
signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jorissen RN, Walker F, Pouliot N, Garrett
TP, Ward CW and Burgess AW: Epidermal growth factor receptor:
Mechanisms of activation and signalling. Exp Cell Res. 284:31–53.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Temam S, Kawaguchi H, El-Naggar AK,
Jelinek J, Tang H, Liu DD, Lang W, Issa JP, Lee JJ and Mao L:
Epidermal growth factor receptor copy number alterations correlate
with poor clinical outcome in patients with head and neck squamous
cancer. J Clin Oncol. 25:2164–2170. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R,
Hammond EH, Fu KK and Milas L: Impact of epidermal growth factor
receptor expression on survival and pattern of relapse in patients
with advanced head and neck carcinoma. Cancer Res. 62:7350–7356.
2002.PubMed/NCBI
|
|
16
|
Bonner JA, Harari PM, Giralt J, Cohen RB,
Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, et al:
Radiotherapy plus cetuximab for locoregionally advanced head and
neck cancer: 5-year survival data from a phase 3 randomised trial,
and relation between cetuximab-induced rash and survival. Lancet
Oncol. 11:21–28. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fung C and Grandis JR: Emerging drugs to
treat squamous cell carcinomas of the head and neck. Expert Opin
Emerg Drugs. 15:355–373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ohnishi Y, Yasui H, Kakudo K and Nozaki M:
Cetuximab-resistant oral squamous cell carcinoma cells become
sensitive in anchorage-independent culture conditions through the
activation of the EGFR/AKT pathway. Int J Oncol. 47:2165–2172.
2015.PubMed/NCBI
|
|
19
|
Ohnishi Y, Yasui H, Kakudo K and Nozaki M:
Regulation of cell migration via EGFR signaling in oral squamous
cell carcinoma. Oncol Lett. 13:930–936. 2017.PubMed/NCBI
|
|
20
|
Birchmeier C, Birchmeier W, Gherardi E and
Woude GF Vande: Met, metastasis, motility and more. Nat Rev Mol
Cell Biol. 4:915–925. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Benvenuti S and Comoglio PM: The MET
receptor tyrosine kinase in invasion and metastasis. J Cell
Physiol. 213:316–325. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma PC, Maulik G, Christensen J and Salgia
R: c-Met: Structure, functions and potential for therapeutic
inhibition. Cancer Metastasis Rev. 22:309–325. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peruzzi B and Bottaro DP: Targeting the
c-Met signaling pathway in cancer. Clin Cancer Res. 12:3657–3660.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hui AY, Meens JA, Schick C, Organ SL, Qiao
H, Tremblay EA, Schaeffer E, Uniyal S, Chan BM and Elliott BE: Src
and FAK mediate cell-matrix adhesion-dependent activation of Met
during transformation of breast epithelial cells. J Cell Biochem.
107:1168–1181. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Henderson V, Smith B, Burton LJ, Randle D,
Morris M and Odero-Marah VA: Snail promotes cell migration through
PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent
pathways during prostate cancer progression. Cell Adhes Migr.
9:255–264. 2015. View Article : Google Scholar
|
|
26
|
Lin CW, Sun MS, Liao MY, Chung CH, Chi YH,
Chiou LT, Yu J, Lou KL and Wu HC: Podocalyxin-like 1 promotes
invadopodia formation and metastasis through activation of
Rac1/Cdc42/cortactin signaling in breast cancer cells.
Carcinogenesis. 35:2425–2435. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rottner K and Stradal TE: Actin dynamics
and turnover in cell motility. Curr Opin Cell Biol. 23:569–578.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Usatyuk PV, Fu P, Mohan V, Epshtein Y,
Jacobson JR, Gomez-Cambronero J, Wary KK, Bindokas V, Dudek SM,
Salgia R, et al: Role of c-Met/phosphatidylinositol 3-kinase
(PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated
lamellipodia formation, reactive oxygen species (ROS) generation,
and motility of lung endothelial cells. J Biol Chem.
289:13476–13491. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Michael M, Vehlow A, Navarro C and Krause
M: c-Abl, Lamellipodin, and Ena/VASP proteins cooperate in dorsal
ruffling of fibroblasts and axonal morphogenesis. Curr Biol.
20:783–791. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Law AL, Vehlow A, Kotini M, Dodgson L,
Soong D, Theveneau E, Bodo C, Taylor E, Navarro C, Perera U, et al:
Lamellipodin and the Scar/WAVE complex cooperate to promote cell
migration in vivo. J Cell Biol. 203:673–689. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takeshita A, Iwai S, Morita Y,
Niki-Yonekawa A, Hamada M and Yura Y: Wnt5b promotes the cell
motility essential for metastasis of oral squamous cell carcinoma
through active Cdc42 and RhoA. Int J Oncol. 44:59–68.
2014.PubMed/NCBI
|
|
32
|
Ma PC, Jagadeeswaran R, Jagadeesh S,
Tretiakova MS, Nallasura V, Fox EA, Hansen M, Schaefer E, Naoki K,
Lader A, et al: Functional expression and mutations of c-Met and
its therapeutic inhibition with SU11274 and small interfering RNA
in non-small cell lung cancer. Cancer Res. 65:1479–1488. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wehrle-Haller B and Imhof BA: Actin,
microtubules and focal adhesion dynamics during cell migration. Int
J Biochem Cell Biol. 35:39–50. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Krause M, Leslie JD, Stewart M, Lafuente
EM, Valderrama F, Jagannathan R, Strasser GA, Rubinson DA, Liu H,
Way M, et al: Lamellipodin, an Ena/VASP ligand, is implicated in
the regulation of lamellipodial dynamics. Dev Cell. 7:571–583.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hsu PC, You B, Yang YL, Zhang WQ, Wang YC,
Xu Z, Dai Y, Liu S, Yang CT, Li H, et al: YAP promotes erlotinib
resistance in human non-small cell lung cancer cells. Oncotarget.
7:51922–51933. 2016.PubMed/NCBI
|
|
36
|
Ritter CA and Arteaga CL: The epidermal
growth factor receptor-tyrosine kinase: A promising therapeutic
target in solid tumors. Semin Oncol. 30 Suppl 1:3–11. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kuhlmann CR, Schaefer CA, Fehsecke A, Most
AK, Tillmanns H and Erdogan A: A new signaling mechanism of
hepatocyte growth factor-induced endothelial proliferation. J
Thromb Haemost. 3:2089–2095. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wondergem R, Ecay TW, Mahieu F, Owsianik G
and Nilius B: HGF/SF and menthol increase human glioblastoma cell
calcium and migration. Biochem Biophys Res Commun. 372:210–215.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tan CS, Gilligan D and Pacey S: Treatment
approaches for EGFR-inhibitor-resistant patients with
non-small-cell lung cancer. Lancet Oncol. 16:e447–e459. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu X, Miyamoto S and Mekada E: Integrin α
2 β 1-dependent EGF receptor activation at cell-cell contact sites.
J Cell Sci. 113:2139–2147. 2000.PubMed/NCBI
|
|
41
|
Bill HM, Knudsen B, Moores SL, Muthuswamy
SK, Rao VR, Brugge JS and Miranti CK: Epidermal growth factor
receptor-dependent regulation of integrin-mediated signaling and
cell cycle entry in epithelial cells. Mol Cell Biol. 24:8586–8599.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang Z: Transactivation of epidermal
growth factor receptor by G protein-coupled receptors: Recent
progress, challenges and future research. Int J Mol Sci.
17:E952016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Díaz B, Yuen A, Iizuka S, Higashiyama S
and Courtneidge SA: Notch increases the shedding of HB-EGF by
ADAM12 to potentiate invadopodia formation in hypoxia. J Cell Biol.
201:279–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ohnishi Y, Inoue H, Furukawa M, Kakudo K
and Nozaki M: Heparin-binding epidermal growth factor-like growth
factor is a potent regulator of invasion activity in oral squamous
cell carcinoma. Oncol Rep. 27:954–958. 2012.PubMed/NCBI
|
|
45
|
Dulak AM, Gubish CT, Stabile LP, Henry C
and Siegfried JM: HGF-independent potentiation of EGFR action by
c-Met. Oncogene. 30:3625–3635. 2011. View Article : Google Scholar : PubMed/NCBI
|
